Pharmacogenetics and Metabolic Disease

作者: Simon Constable , Munir Pirmohamed

DOI: 10.3109/9781420016697-13

关键词:

摘要:

参考文章(376)
Kimberly A. Dornbrook-Lavender, John A. Pieper, Genetic polymorphisms in emerging cardiovascular risk factors and response to statin therapy. Cardiovascular Drugs and Therapy. ,vol. 17, pp. 75- 82 ,(2003) , 10.1023/A:1024212026578
Shin-Ichi Usami, Satoko Abe, Hideichi Shinkawa, William J. Kimberling, Sensorineural hearing loss caused by mitochondrial dna mutations: Special reference to the A1555G mutation Journal of Communication Disorders. ,vol. 31, pp. 423- 435 ,(1998) , 10.1016/S0021-9924(98)00014-8
W W Weber, D W Hein, N-acetylation pharmacogenetics. Pharmacological Reviews. ,vol. 37, pp. 25- 79 ,(1985)
S. Saito, A. Iida, A. Sekine, Y. Miura, C. Ogawa, S. Kawauchi, S. Higuchi, Y. Nakamura, Identification of 779 genetic variations in eight genes encoding members of the ATP-binding cassette, subfamily C (ABCC/MRP/CFTR. Journal of Human Genetics. ,vol. 47, pp. 147- 171 ,(2002) , 10.1007/S100380200018
I. Barroso, M. Gurnell, V. E. F. Crowley, M. Agostini, J. W. Schwabe, M. A. Soos, G. LI Maslen, T. D. M. Williams, H. Lewis, A. J. Schafer, V. K. K. Chatterjee, S. O'Rahilly, Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension Nature. ,vol. 402, pp. 880- 883 ,(1999) , 10.1038/47254
Toshiyuki Sakaeda, Tsutomu Nakamura, Masanori Horinouchi, Mikio Kakumoto, Nobuko Ohmoto, Toshiyuki Sakai, Yoshinori Morita, Takao Tamura, Nobuo Aoyama, Midori Hirai, Masato Kasuga, Katsuhiko Okumura, MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharmaceutical Research. ,vol. 18, pp. 1400- 1404 ,(2001) , 10.1023/A:1012244520615
Karani Santhanakrishnan Vimaleswaran, R Deepa, Radha, Mohan, The genetics of diabetes mellitus. Indian Journal of Medical Research. ,vol. 117, pp. 225- 238 ,(2003)
Michael A. Crouch, Patrick L. McCollam, Philippe Arnaud, Caucasian versus African‐American Differences in Orosomucoid: Potential Implications for Therapy Pharmacotherapy. ,vol. 18, pp. 620- 626 ,(1998) , 10.1002/J.1875-9114.1998.TB03125.X
Samir S. Deeb, Lluis Fajas, Masami Nemoto, Jussi Pihlajamäki, Leena Mykkänen, Johanna Kuusisto, Markku Laakso, Wilfred Fujimoto, Johan Auwerx, A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genetics. ,vol. 20, pp. 284- 287 ,(1998) , 10.1038/3099